GoodRx Holdings Inc
For the period ended Mar 31, 2024. Filed May 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 9, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Incorporated by Reference · Filed/FurnishedHerewith | ||||||
|---|---|---|---|---|---|---|
| ExhibitNumber · Exhibit Description · Form · File No. · Exhibit · FilingDate | ||||||
| 3.1 | Amended and Restated Certificate of Incorporation | 8-K | 001-39549 | 3.1 | 9/28/20 | |
| 3.2 | Amended and Restated Bylaws | 8-K | 001-39549 | 3.2 | 9/28/20 | |
| 4.1 | Form of Certificate of Class A Common Stock | S-1 | 333-248465 | 4.1 | 8/28/20 | |
| 4.2 | Form of Certificate of Class B Common Stock | S-8 | 333-249069 | 4.4 | 9/25/20 | |
| 10.1 | Fourth Amendment to Office Lease Agreement by and between GoodRx, Inc. and Pen Factory Property Owner, LLC, dated February 7, 2024 | * | ||||
| 10.2† | Fifth Amendment to First Lien Credit Agreement, dated February 20, 2024 | 8-K | 001-39549 | 10.1 | 2/26/24 | |
| 10.3† | Separation Agreement & Release, by and between GoodRx, Inc. and Raj Beri, dated February 22, 2024 | 8-K | 001-39549 | 10.2 | 2/26/24 | |
| 10.4 | Employment Agreement, by and between GoodRx, Inc. and Karsten Voermann, dated March 4, 2024 | 8-K | 001-39549 | 10.1 | 3/7/24 | |
| 10.5 | First Amendment to Employment Agreement, by and between GoodRx, Inc. and Scott Wagner, dated March 13, 2024 | 8-K | 001-39549 | 10.1 | 3/14/24 | |
| 10.6 | Non-Employee Director Deferred Compensation Plan | 10-K | 001-39549 | 10.18 | 2/29/24 | |
| 10.6.1 | Form of Director Deferred Cash Fees RSU Agreement | 10-K | 001-39549 | 10.18.1 | 2/29/24 | |
| 10.6.2 | Form of Director Deferred RSU Agreement | 10-K | 001-39549 | 10.18.2 | 2/29/24 | |
| 31.1 | Certification of Interim Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) | * | ||||
| 31.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) | * | ||||
| 32.1 | Certification of Interim Chief Executive Officer pursuant to 18 U.S.C. Section 1350 | ** | ||||
| 32.2 | Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350 | ** | ||||
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | * | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | * | ||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | * | ||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | * | ||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | * | ||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | * | ||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | * | ||||
*Filed herewith.
**Furnished herewith.
†The annexes, schedules, and certain exhibits to this Exhibit have been omitted pursuant to Item 601(a)(5) of Regulation
S-K. The Registrant hereby agrees to furnish supplementally a copy of any omitted annex, schedule or exhibit to the
SEC upon request.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.